Shopping Cart
Remove All
Your shopping cart is currently empty
Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor with a Ki of 0.59 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $199 | - | In Stock |
| Description | Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor with a Ki of 0.59 nM. |
| Targets&IC50 | Aurora B:5597.14 nM (Ki), Aurora A:1239 nM (Ki), PLK4:0.59 nM (Ki), PLK4 (G95L):497.53 nM (Ki) |
| In vitro | Centrinone-B (LCR-323) is a highly potent and selective PLK4 inhibitor that can reduce centrosomes without affecting Aurora A/B, and it induces apoptosis in most melanoma cell lines[2]. |
| Synonyms | LCR-323, LCR323, LCR 323 |
| Molecular Weight | 631.67 |
| Formula | C27H27F2N7O5S2 |
| Cas No. | 1798871-31-4 |
| Smiles | COc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(cc2F)S(=O)(=O)Cc2cccc(c2F)[N+]([O-])=O)nc1N1CCCCC1 |
| Relative Density. | 1.54 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (31.66 mM), Sonication is recommended. H2O: < 0.1 mg/mL (insoluble) | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 2 mg/mL (3.17 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.